Logo Logo
Hilfe
Hilfe
Switch Language to English

Rauscher, Isabel; Maurer, Tobias; Fendler, Wolfgang P.; Sommer, Wieland H.; Schwaiger, Markus und Eiber, Matthias (2016): Ga-68-PSMA ligand PET/CT in patients with prostate cancer: How we review and report. In: Cancer Imaging 16:14 [PDF, 1MB]

[thumbnail of 10.1186_s40644-016-0072-6.pdf]
Vorschau
Download (1MB)

Abstract

Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging of primary prostate cancer and restaging after biochemical recurrence with Ga-68-PSMA ligand Positron emission tomography/computed tomography (PET/CT). However, prospective trials and clinical guidelines for this new technique are still missing. Therefore, we summarized our experience with Ga-68-PSMA ligand PET/CT examinations in patients with primary PC and biochemical recurrence. It focuses on the technical and logistical aspects of Ga-68-PSMA ligand PET/CT examination as well as on the specific background for image reading discussing also potential pitfalls. Further, it includes relevant issues on free-text as well as structured reporting used in daily clinical routine.

Dokument bearbeiten Dokument bearbeiten